Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics: 2021 update. Circulation. 2021;143:e254-743.

Article  Google Scholar 

Lorts A, Conway J, Schweiger M, Adachi I, Amdani S, Auerbach SR, et al. ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. J Hear Lung Transplant. 2021;40:709–32.

Article  Google Scholar 

Azevedo PS, Polegato BF, Minicucci MF, Paiva SAR, Zornoff LAM. Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 2016;106:62–9.

CAS  Google Scholar 

Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35(3):569–82.

Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98–102.

Article  CAS  Google Scholar 

Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, et al. Dynamics of cell generation and turnover in the human heart. Cell. 2016;161:1556–75.

Google Scholar 

Montero P, Flandes-Iparraguirre M, Musquiz S, Pérez Araluce M, Plano D, Sanmartín C, et al. Cells, materials, and fabrication processes for cardiac tissue engineering. Front Bioeng Biotechnol. 2020;8:955.

Article  Google Scholar 

Nguyen PK, Rhee JW, Wu JC. Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review. JAMA Cardiol. 2016;1:831–41.

Article  Google Scholar 

Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. 1995;92:7844–8.

Article  CAS  Google Scholar 

Gao F, Chiu SM, Motan DAL, Zhang Z, Chen L, Ji HL, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7:e2062–e2062.

Article  CAS  Google Scholar 

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.

Article  CAS  Google Scholar 

Mummery CL, Zhang J, Ng E, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human ES and iPS cells to cardiomyocytes: a methods overview. Circ Res. 2012;111:344–58.

Article  CAS  Google Scholar 

Palpant NJ, Pabon L, Friedman CE, Roberts M, Hadland B, Zaunbrecher RJ, et al. Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells. Nat Protoc. 2017;12:15–31.

Article  CAS  Google Scholar 

Lee JH, Protze SI, Laksman Z, Backx PH, Keller GM. Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations. Cell Stem Cell. 2017;21:179-194.e4.

Article  CAS  Google Scholar 

Karakikes I, Senyei GD, Hansen J, Kong CW, Azeloglu EU, Stillitano F, et al. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Transl Med. 2014;3:18–31.

Article  CAS  Google Scholar 

Harsoyo A, Suparto IH, Yuniadi Y, Boediono A, Sajuthi D. Differentiation of cardiomyocytes and identification of cardiac conduction system connexins derived from bone marrow mesenchymal stem cells of Macaca nemestrina. HAYATI J Biosci. 2020;27:337.

Article  Google Scholar 

James EC, Tomaskovic-Crook E, Crook JM. Bioengineering clinically relevant cardiomyocytes and cardiac tissues from pluripotent stem cells. Int J Mol Sci. 2021;22:1–34.

Article  Google Scholar 

Ahmed RE, Anzai T, Chanthra N, Uosaki H. A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes. Front Cell Dev Biol. 2020;8:1–9.

Article  CAS  Google Scholar 

Bedada FB, Chan SSK, Metzger SK, Zhang L, Zhang J, Garry DJ, et al. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports. 2014;3:594–605.

Article  CAS  Google Scholar 

Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J. 2013;77:1307–14.

Article  CAS  Google Scholar 

Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden RWJ, et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell. 2020;26:862-879.e11.

Article  CAS  Google Scholar 

Mills RJ, Titmarsh DM, Koenig X, Parker BL, Ryall JG, Quaife-Ryan GA, et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc Natl Acad Sci. 2017;114:E8372 LP-E8381.

Article  Google Scholar 

Feric NT, Pallotta I, Singh R, Bogdanowicz DR, Gustilo M, Chaudhary K, et al. Engineered cardiac tissues generated in the Biowire™ II: a platform for human-based drug discovery. Toxicol Sci. 2019;172:89–97.

Article  CAS  Google Scholar 

Crestani T, Steichen C, Neri E, Rodrigues M, Fonseca-Alaniz MH, Ormrod B, et al. Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells. Biochem Biophys Res Commun. 2020;533:376–82.

Article  CAS  Google Scholar 

Branco MA, Cotovio JP, Rodrigues CAV, Vaz SH, Fernandes TG, Moreira LM, et al. Transcriptomic analysis of 3D cardiac differentiation of human induced pluripotent stem cells reveals faster cardiomyocyte maturation compared to 2D culture. Sci Rep. 2019;9:9229.

Article  Google Scholar 

Khan K, Gasbarrino K, Mahmoud I, Makhoul G, Yu B, Dufresne L, et al. Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haemato. Syst Rev. 2018;7:1–7.

Google Scholar 

Dattola E, Parrotta EI, Scalise S, Perozziello G, Limongi T, Candeloro P, et al. Development of 3D PVA scaffolds for cardiac tissue engineering and cell screening applications. RSC Adv. 2019;9:4246–57.

Article  CAS  Google Scholar 

Inayati R, Suhaeri M, Fahdia N, Remelia M, Antarianto RD. Optimization of hybrid PVA/hFDM scaffold preparation. AIP Conf Proc. 2021;1:2344. https://doi.org/10.1063/5.0049156.

Article  CAS  Google Scholar 

Khan M, Xu Y, Hua S, Johnson J, Belevych A, Janssen PML, et al. Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) cultured on an aligned-nanofiber cardiac patch. PLoS ONE. 2015;10:1–19.

Article  Google Scholar 

Noor N, Shapira A, Edri R, Gal I, Wertheim L, Dvir T. 3D Printing of personalized thick and perfusable cardiac patches and hearts. Adv Sci. 2019;6:1900344.

Article  Google Scholar 

Beauchamp P, Jackson CB, Ozhathil LC, Agarkova I, Galindo CL, Sawyer DB, et al. 3D co-culture of hiPSC-derived cardiomyocytes with cardiac fibroblasts improves tissue-like features of cardiac spheroids. Front Mol Biosci. 2020;7:14.

Article  CAS  Google Scholar 

Yang X, Rodriguez M, Pabon L, Fischer KA, Reinecke H, Regnier M, et al. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol. 2014;72:296–304.

Article  CAS  Google Scholar 

Ye L, Chang YH, Xiong Q, Zhang P, Zhang L, Somasundaram P, et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014;15:750–61.

Article  CAS  Google Scholar 

Vasanthan V, Shim HB, Teng G, Belke D, Svystonyuk D, Deniset JF, et al. Acellular biomaterial modulates myocardial inflammation and promotes endogenous mechanisms of postinfarct cardiac repair. J Thorac Cardiovasc Surg. 2021;S0022-5223(21):01824-9.

Wang Z, Wang Z, Lu WW, Zhen W, Yang D, Peng S. Novel biomaterial strategies for controlled growth factor delivery for biomedical applications. NPG Asia Mater. 2017;9:e435–517.

Article  CAS  Google Scholar 

Smagul S, Kim Y, Smagulova A, Raziyeva K, Nurkesh A, Saparov A. Biomaterials loaded with growth factors/cytokines and stem cells for cardiac tissue regeneration. Int J Mol Sci. 2020;21:1–20.

Article  Google Scholar 

Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials. 2004;25:1639–47.

Article  CAS  Google Scholar 

Breckwoldt K, Letuffe-Brenière D, Mannhardt I, Schulze T, Ulmer B, Werner T, et al. Differentiation of cardiomyocytes and generation of human engineered heart tissue. Nat Protoc. 2017;12:1177–97.

Article  CAS  Google Scholar 

Mannhardt I, Breckwoldt K, Letuffe-Brenière D, Schaaf S, Schulz H, Neuber C, et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Reports. 2016;7:29–42.

Article  CAS  Google Scholar 

Saleem U, Mannhardt I, Braren I, Denning C, Eschenhagen T, Hansen A. Force and calcium transients analysis in human engineered heart tissues reveals positive force-frequency relation at physiological frequency. Stem Cell Reports. 2020;14:312–24.

Article  CAS  Google Scholar 

Saleem U, Meer BJV, Katili PA, Yusof NANM, Mannhardt I, Garcia AK, et al. Blinded, multicenter evaluation of drug-induced changes in contractility using human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2020;176:103–23.

Article  CAS  Google Scholar 

Grosberg A, Alford PW, McCain ML, Parker KK. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip. 2011;11:4165–73.

Article  CAS  Google Scholar 

Yang Q, Xiao Z, Lv X, Zhang T, Liu H. Fabrication and biomedical applications of heart-on-a-chip. Int J bioprinting. 2021;7:370.

Article  Google Scholar 

Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med. 2014;20:616–23.

Article  CAS  Google Scholar 

Helms HR, Jarrell DK, Jacot JG. Generation of cardiac organoids using cardiomyocytes, endothelial cells, epicardial cells, and cardiac fibroblasts derived from human induced pluripotent stem cells. FASEB J. 2019;33:lb170–lb170.

Article  Google Scholar